VTYX vs AMLX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VTYX Captures Institutional Edge (2โ1 Pillars ยท 2โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ventyx Biosciences, Inc. Common Stock (VTYX) driven by superior Momentum & Technical, Options & Structure while AMLX counters with relative strength in Valuation. Fundamentally, VTYX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AMLX at 2.8x Forward P/E and 0.0% operating margin (-99.6% YoY). In options structure, VTYX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against AMLX sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VTYX | AMLX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.0B | $3.8B | Larger Scale | AMLX |
| Trailing P/E Ratio Valuation | N/M | 2.8x | Lower Multiple | AMLX |
| Forward P/E Ratio Valuation | N/M | 2.8x | Lower Multiple | AMLX |
| Revenue Growth (YoY) Growth | +0.0% | -99.6% | Higher Growth | VTYX |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -45.4% | -30.1% | Higher ROE | AMLX |
| 52-Week Range Position Momentum | 55% ($1โ$25) | 57% ($11โ$41) | Stronger Trend | AMLX |
| Beta / 30D Volatility Risk Regime | 2.07ฮฒ ยท 2% Vol | 1.17ฮฒ ยท 61% Vol | Lower Realized Risk | VTYX |
| Unified Institutional Score Composite Signal | 50.4 / 100 (HOLD) | 59.8 / 100 (HOLD) | Higher Composite | AMLX |